Cover Image

Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab

Abstract is missing (Short communication)

Saved in:

Bibliographic Details
Main Authors:	Shoko Miyamoto (Author), Yasutomo Imai (Author), Masaru Natsuaki (Author), Kiyofumi Yamanishi (Author), Nobuo Kanazawa (Author)
Format:	Book
Published:	Medical Journals Sweden, 2022-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dupilumab in atopic dermatitis patients with chronic hepatitis B
by: Masako Matsutani, et al.
Published: (2022)

Evaluation of long‐term disease control with dupilumab therapy using the Atopic Dermatitis Control Tool in real‐world clinical practice
by: Marin Kunimoto, et al.
Published: (2022)

Dupilumab treatment reduces serum SCCA2 levels in patients with atopic dermatitis
by: Kanako Kita, et al.
Published: (2023)

Real‐world use of dupilumab for 53 patients with atopic dermatitis in Japan
by: Masako Matsutani, et al.
Published: (2020)

Dupilumab Effects on Innate Lymphoid Cell and Helper T Cell Populations in Patients with Atopic Dermatitis
by: Yasutomo Imai, et al.
Published: (2021)

Allergic Contact Dermatitis Due to Ripasudil Hydrochloride Hydrate in Eye-drops: A Case Report
by: Minori Kusakabe, et al.
Published: (2017)

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
by: Danielle M. Peterson, MD, et al.
Published: (2021)

New Era in Atopic Dermatitis Treatment: Results of Long-Term Dupilumab Administration
by: Nikolay N. Murashkin, et al.
Published: (2021)

Clinical remission of disseminated molluscum contagiosum infection in a patient with atopic dermatitis treated with dupilumab
by: Marta Elosua-González, et al.
Published: (2022)

Dupilumab in Patients with Atopic Dermatitis: A Multicentric, Long-Term, Real-World Portuguese Study
by: Tiago Torres, et al.
Published: (2024)

Alopecia areata after dupilumab for atopic dermatitis
by: Krystal Mitchell, MBA, et al.
Published: (2018)

Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023)

Monitoring Cellular Movement with Photoconvertible Fluorescent Protein and Single-Cell RNA Sequencing Reveals Cutaneous Group 2 Innate Lymphoid Cell Subtypes, Circulating ILC2 and Skin-Resident ILC2
by: Minori Nakatani-Kusakabe, et al.
Published: (2021)

A Case of Old Age-Onset Generalized Pustular Psoriasis with a Deficiency of IL-36RN (DITRA) Treated by Granulocyte and Monocyte Apheresis
by: Chiharu Tominaga, et al.
Published: (2015)

The therapy of atopic dermatitis in acute phase and in remission
by: Arianna Giannetti, et al.
Published: (2024)

Efficacy of dupilumab in moderate and severe atopic dermatitis
by: Stephan Weidinger, et al.
Published: (2023)

Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
by: Shan J, et al.
Published: (2022)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
by: Amanda E. Zubek, MD, PhD, et al.
Published: (2021)

Conjunctivitis in patients with atopic dermatitis treated with dupilumab
by: Sandra Ferreira, et al.
Published: (2020)

Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study
by: Alexa B. Kimball, et al.
Published: (2023)

Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024)

Dupilumab treatment of a case of asthma, chronic rhinosinusitis, and atopic dermatitis after initial benralizumab administration
by: Haruna Matsuda‐Hirose, et al.
Published: (2020)

Uveitis and hypereosinophilia associated with dupilumab in an atopic dermatitis patient
by: Shiyu Zhang, et al.
Published: (2023)

Dupilumab normalizes correlates of lysosomal function in atopic dermatitis
by: Christina Bürgler, et al.
Published: (2024)

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
by: Sung Kyung Cho, BA, et al.
Published: (2021)

The application of the biological treatment in atopic dermatitis: focus on dupilumab
by: Yu. S. Smolkin, et al.
Published: (2023)

Alopecia areata-like and psoriasis after dupilumab use for atopic dermatitis,
by: Viviane Maria Maiolini, et al.
Published: (2021)

Long-term Remission of Severe and Refractory Chronic Actinic Dermatosis with Dupilumab: A Case Report with Review of the Literature
by: Clélia Vanhaecke, et al.
Published: (2024)

Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis
by: Andreas Wollenberg, et al.
Published: (2022)

Anti‐BP230 antibody-positive bullous pemphigoid complicated by ulcerative colitis
by: Mayu Fujimoto, et al.
Published: (2019)

Switching to ixekizumab improves adalimumab‐induced interstitial lung disease in patients with psoriatic arthritis: A case report
by: Hideki Hayashi, et al.
Published: (2021)

Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis
by: Lina U. Ivert, et al.
Published: (2019)

Conjunctivitis as a common adverse effect of dupilumab in atopic dermatitis
by: Mikołaj Cichoń, et al.
Published: (2023)

Effectiveness of dupilumab for chronic prurigo in elderly patients with atopic dermatitis
by: Shinji Mitsuyama, et al.
Published: (2023)

Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
by: Maria Esposito, MD, et al.
Published: (2023)

Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis
by: Emilie Fowler, et al.
Published: (2019)

Dupilumab: Direct Cost and Clinical Evaluation in Patients with Atopic Dermatitis
by: Marco Ferrari, et al.
Published: (2023)

Drug survival rate of dupilumab in Japanese patients with atopic dermatitis
by: Susumu Ichiyama, et al.
Published: (2021)

Dupilumab-induced phenotype switching from atopic dermatitis to psoriasis
by: Aakaash Varma, BA, et al.
Published: (2020)

A Review of Dupilumab in the Treatment of Atopic Dermatitis in Infants and Children
by: Wang M, et al.
Published: (2024)